UC Irvine Health Neuropsychiatric Center

UC Irvine Health Neuropsychiatric Center

Services:
Facility Vaping Policy
• Vaping not permitted

Testing

• Metabolic syndrome monitoring
• Laboratory testing

Payment/Insurance/Funding Accepted

• Cash or self-payment
• State welfare or child and family services funds
• Federal military insurance (e.g., TRICARE)
• Other State funds
• Medicare
• Medicaid
• County or local government funds
• State mental health agency (or equivalent) funds
• State-financed health insurance plan other than Medicaid
• Private health insurance

Education and Counseling Services

• Smoking/vaping/tobacco cessation counseling

Age Groups Accepted

• Children/Adolescents
• Adults
• Young Adults

Type of Care

• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
• Mental health treatment

Ancillary Services

• Chronic disease/illness management
• Suicide prevention services
• Case management service
• Legal advocacy
• Court-ordered outpatient treatment
• Psychosocial rehabilitation services
• Diet and exercise counseling

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Hospital inpatient/24-hour hospital inpatient

Assessment/Pre-treatment

• Screening for tobacco use

Facility Smoking Policy

• Smoking not permitted

Facility Operation (e.g., Private, Public)

• State government

Recovery Support Services

• Mentoring/peer support

Language Services

• Sign language services for the deaf and hard of hearing

Treatment Approaches

• Group therapy
• Electroconvulsive therapy
• Integrated Mental and Substance Use Disorder treatment
• Activity therapy

Facility Type

• Separate inpatient psychiatric unit of a general hospital

Emergency Mental Health Services

• Psychiatric emergency walk-in services
• Psychiatric emergency onsite services

Special Programs/Groups Offered

• Persons 18 and older with serious mental illness (SMI)
• Children/adolescents with serious emotional disturbance (SED)
• Clients with HIV or AIDS
• Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
• Clients with co-occurring mental and substance use disorders
• Clients who have experienced trauma
• Persons with post-traumatic stress disorder (PTSD)

Pharmacotherapies

• Nicotine replacement
• Paliperidone
• Antipsychotics used in treatment of SMI
• Olanzapine
• Prochlorperazine
• Haloperidol
• Fluphenazine
• Clozapine
• Loxapine
• Droperidol
• Asenapine
• Quetiapine
• Non-nicotine smoking/tobacco cessation
• Aripiprazole
• Lurasidone
• Chlorpromazine
• Thiothixene
• Risperidone
• Ziprasidone